Health Bulletin 24/October/2025

Written By :  Anshika Mishra
Published On 2025-10-24 12:17 GMT   |   Update On 2025-10-24 12:17 GMT
Advertisement

Here are the top health stories for the day:

NEET SS 2025 rescheduled to December 26 and 27: NBE

The National Board of Examinations in Medical Sciences (NBEMS) has revised the National Eligibility and Entrance Test-Super Speciality (NEET-SS) exam dates for the academic year 2025.

According to the notice issued by the NBEMS in this regard, the NEET-SS 2025 exam will now be held on December 26 and 27, 2025. The exam was previously scheduled for December 27th and 28th, 2025, and then postponed from the earlier dates of November 7th and 8th.

Advertisement

For more details, check out the full story on the link mentioned below:

NEET SS 2025 now on December 26th, 27th: NBE


Rajasthan cautions private medical colleges against excess MBBS fees under unapproved quota

Taking cognisance of the "unapproved" 15 per cent management quota MBBS seats at private medical colleges, the Rajasthan Government has issued a strict warning to those institutions and asked them only to charge the fee authorised by the state-level fee regulatory committee.

Furthermore, the State Government has also instructed medical colleges to refund the excess fee collected at an annual interest rate of 12%.

For more details, check out the full story on the link mentioned below:

Rajasthan warns private medical colleges against charging higher MBBS fees under 15 percent 'unapproved' management quota


Mizoram records 121 deaths from multidrug-resistant TB since January

Emphasising the urgent need for continued vigilance and improved access to advanced treatment options, the National TB Elimination Programme (NTEP) under the National Health Mission (NHM) reported 121 deaths between January and October 10, officials

According to a UNI report, NTEP officials reported that 1,870 new TB cases were detected from 97,467 samples tested during the period. Of these, 1,126 are men and 744 women, reflecting the persistence of the disease across gender and age groups.

For more details, check out the full story on the link mentioned below:

Mizoram reports 121 multidrug-resistant TB Deaths since January


OGH study flags rise in mystery kidney disease among healthy youth in Hyderabad

A mysterious kidney disease known as Chronic Kidney Disease of unknown etiology (CKDu) is increasingly affecting younger, non-diabetic, urban populations in Hyderabad and surrounding Telangana districts, according to a study led by nephrologists from Osmania General Hospital (OGH) and Apollo Hospitals. Published in the Indian Journal of Nephrology in August 2024, the study highlights that, unlike traditional CKDu cases linked to agricultural labor and heat stress, this urban cohort includes small business owners and service workers with no farming background.

The disease progresses silently, often only detected when kidney damage is severe, requiring urgent dialysis or renal replacement therapy. Kidney biopsies revealed significant scarring and inflammation in the kidney filters, confirming early silent damage. Notably, 40% of patients had a history of consuming unregulated herbal medicines, a potential risk factor requiring closer investigation. Dr. Manisha Sahay, Head of Nephrology at OGH, stresses the urgent need for public health to focus on this urban CKDu subset to improve early diagnosis and preventive strategies.

Reference: Ramavajula, Anitha and Sahay, Manisha and Ismal, Kiranmai and Kavadi, Anuradha and Enganti, Rama and Gowrishankar, Swarnalata; Chronic Kidney Disease of Unknown Etiology in Telangana: Is It Different?; Indian Journal of Nephrology; doi = 10.25259/IJN_257_2024

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News